🎙️ We’re back with the fifth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.
This week’s Article of the Week explores an exciting area of research:
In this episode, Professor Bas Bloem reviews two groundbreaking studies marking a major step forward in regenerative medicine for Parkinson’s disease: a Phase I trial of hES cell-derived dopaminergic neurons and a Phase I/II trial of iPS-cell-derived dopaminergic cells. He discusses the scientific progress, safety outcomes, and the potential of stem cell therapies to transform future Parkinson’s treatment.
👉 You can read the full articles below:
Phase I: https://www.nature.com/articles/s41586-025-08845-y
Phase I/II: https://www.nature.com/articles/s41586-025-08700-0Â
Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.
View all episodes
By Oruen CNS🎙️ We’re back with the fifth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.
This week’s Article of the Week explores an exciting area of research:
In this episode, Professor Bas Bloem reviews two groundbreaking studies marking a major step forward in regenerative medicine for Parkinson’s disease: a Phase I trial of hES cell-derived dopaminergic neurons and a Phase I/II trial of iPS-cell-derived dopaminergic cells. He discusses the scientific progress, safety outcomes, and the potential of stem cell therapies to transform future Parkinson’s treatment.
👉 You can read the full articles below:
Phase I: https://www.nature.com/articles/s41586-025-08845-y
Phase I/II: https://www.nature.com/articles/s41586-025-08700-0Â
Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.